Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Clinical Study of Ensifentrine-Glycopyrrolate (MK-5884A/RPL554) Fixed-dose Combination Dose Ranging in Participants With COPD (MK-5884A-029/RPL554-CO-212)

ClinicalTrials.gov ID: NCT07016412

Public ClinicalTrials.gov record NCT07016412. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 7:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb, Randomized, Double-blind, Placebo- Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ensifentrine-glycopyrrolate Fixed-dose Combination at Two Dose Levels Compared to Glycopyrrolate or Ensifentrine Monotherapy in Subjects With COPD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the safety and efficacy of fixed dose combinations of ensifentrine with two different glycopyrrolate dose levels compared to placebo and to the individual components of the fixed dose combinations, each administered twice a day via standard jet nebulizer, in adult participants with chronic obstructive pulmonary disease (COPD).

Study identification

NCT ID
NCT07016412
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
497 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2025 (Actual)
Primary completion
Aug 17, 2026 (Actual)
Completion
Aug 17, 2026 (Actual)
Last update posted
Sep 11, 2026

2025 – 2026

United States locations

U.S. sites
57
U.S. states
19
U.S. cities
52
Facility City State ZIP Site status
SEC Clinical Research, LLC Dothan Alabama 36305-7375 —
Elite Clinical Studies, LLC Phoenix Arizona 85018 —
Tucson Clinical Research Institute Tucson Arizona 85712 —
Downtown LA Research Center Inc - ClinEdge Los Angeles California 90017 —
California Medical Research Associates, Inc. Northridge California 91324-6200 —
Northern California Research Corp Sacramento California 95821-2640 —
Clinical Research of West Florida Inc Clearwater Florida 33765 —
Fleming Island Center For Clinical Research Fleming Island Florida 32003 —
Florida Institute For Clinical Research LLC Orlando Florida 32825-4454 —
Ormond Beach Clinical Research Ormond Beach Florida 32174-8196 —
Progressive Medical Research Port Orange Florida 32127-5169 —
Clinical Research of West Florida Inc - Tampa Tampa Florida 33606 —
Centricity Research Columbus Georgia Multispecialty - PPDS Columbus Georgia 31904 —
ASHA Clinical Research - Hammond Hammond Indiana 46324 —
Velocity Clinical Research - Valparaiso Valparaiso Indiana 46383 —
Velocity Clinical Research (Rockville - Maryland) - PPDS Rockville Maryland 20854-2960 —
Revive Research Institute, Inc Southfield Michigan 48075 —
Clinical Research Institute, Inc - CRN Plymouth Minnesota 55441-2676 —
Midwest Chest Consultants PC Saint Charles Missouri 63301 —
Midwest Clinical Research LLC St Louis Missouri 63141-7051 —
The Clinical Research Center LLC - CRN St Louis Missouri 63141 —
Sierra Clinical Research Las Vegas Nevada 89106 —
Trialfinity Clinical Research Center Hamilton New Jersey 08619 —
Horizon Family Medical Group - New Windsor Primary Care New Windsor New York 12553-7754 —
American Health Research Inc Charlotte North Carolina 28277 —
Clinical Research of Gastonia Gastonia North Carolina 28054-7481 —
Stern Research Partners, LLC Huntersville North Carolina 28078 —
Monroe Biomedical Research -343 Venus St Monroe North Carolina 28112-4025 —
Carolina Research Center, Inc Shelby North Carolina 28150-3803 —
Bernstein Clinical Research Center Inc Cincinnati Ohio 45231-4927 —
Remington Davis Clinical Research Columbus Ohio 43215 —
Advance Clinical Research Kettering Ohio 45439 —
Clinical Research Associates of Central PA DuBois Pennsylvania 15801-2277 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Velocity Clinical Research - Anderson - PPDS Anderson South Carolina 29621-4822 —
Pharmacorp Clinical Trials Incorporated Charleston South Carolina 29412 —
Piedmont Research Partners LLC Fort Mill South Carolina 29707-4514 —
Velocity Clinical Research - Gaffney - PPDS Gaffney South Carolina 29340-4737 —
Lowcountry Lung and Critical Care PA North Charleston South Carolina 29406 —
Monroe Biomedical Research Charleston North Charleston South Carolina 29406 —
Clinical Research of Rock Hill Rock Hill South Carolina 29732 —
Spartanburg Medical Research Spartanburg South Carolina 29303-4755 —
Velocity Clinical Research Spartanburg South Carolina 29303 —
Velocity Clinical Research - Union - PPDS Union South Carolina 29379 —
Chattanooga Research & Medicine, PLLC Chattanooga Tennessee 37404 —
ClinSearch - Chattanooga Chattanooga Tennessee 37421 —
Clinical Trials Center of Middle Tennessee Franklin Tennessee 37067-5665 —
MultiSpecialty Clinical Research, Inc Johnson City Tennessee 37604 —
Inquest Clinical Research Baytown Texas 77521 —
Corsicana Medical Research Corsicana Texas 75110-2471 —
Horizon CR: Houston Pulmonary Sleep & Allergy Associates - Cypress - ClinEdge - PPDS Cypress Texas 77429 —
Greater Heights Memorial Pulmonary and Sleep Houston Texas 77008 —
Houston Pulmonary Medicine Associates, PA - Biopharma Informatic - PPDS Houston Texas 77089 —
Huntsville Research Institute LLC Huntsville Texas 77340 —
Element Research Group San Antonio Texas 78258 —
Sherman Clinical Research - 403 N. Highland Ave Sherman Texas 75092 —
Tranquil Clinical Research Webster Texas 77598-4085 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07016412, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 11, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07016412 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →